Acute Kidney Injury
Understanding Acute Kidney Injury (AKI), also known as Acute Renal Failure, is crucial for accurate clinical documentation and medical coding. This resource provides information on AKI diagnosis, including symptoms, causes, and treatment, to support healthcare professionals in proper coding and documentation practices. Learn about the latest guidelines for diagnosing and managing Acute Kidney Injury and Acute Renal Failure, ensuring comprehensive patient care and accurate medical records.
Sudden decline in kidney function, causing waste buildup in the body.
Decreased urine output, swelling, fatigue, nausea, shortness of breath.
Hospitalized patients, severe infections, dehydration, certain medications.
ICD-10 Code Families
Complete code families applicable to N17.9
When to use each related code
| Description | When to use |
|---|---|
| Sudden kidney function decline. | Use for rapid loss of kidney function, often reversible. Consider causes like dehydration, medications. |
| Gradual kidney function loss. | Use for progressive, irreversible kidney damage, often from diabetes or hypertension. Stages 1-5. |
| Kidney damage from reduced blood flow. | Use when kidney injury is due to low blood perfusion, e.g., shock, heart failure. Often part of AKI. |
Best-practice checklist
- ✓AKI diagnosis: Document serum creatinine and urine output.
- ✓Acute Kidney Injury: Specify stage (1, 2, 3) based on KDIGO.
- ✓Acute Renal Failure: Document cause (prerenal, intrinsic, postrenal).
- ✓Document AKI duration and related comorbidities.
- ✓AKI coding: Use ICD-10 code N17.9 for unspecified AKI.
Common pitfalls to avoid
Coding AKI without specifying stage (I, II, III) or cause can lead to lower reimbursement and inaccurate severity reflection.
Misdiagnosis between acute and chronic kidney disease can impact coding accuracy, quality metrics, and treatment plans.
Insufficient documentation of comorbidities like hypertension or diabetes impacting AKI can affect risk adjustment and coding specificity.
Best-practice tips
- 01Hydration: Optimize fluid intake to maintain kidney function. ICD-10 N17
- 02Medication review: Avoid nephrotoxic drugs. RxNorm, CDI, quality measures
- 03Monitor renal function: Regular creatinine, GFR checks. SNOMED CT, compliance
- 04Control comorbidities: Manage diabetes, hypertension. HCC coding, risk adjustment
- 05Early diagnosis: Prompt treatment crucial for AKI. ICD-10, clinical validity
Step-by-step checklist
- 1
Verify serum creatinine increase >=0.3 mg/dL within 48 hours (ICD-10 N17.9)
- 2
Check urine output <0.5 mL/kg/hour for 6 hours (AKI staging, patient safety)
- 3
Review medications for nephrotoxicity (drug-induced AKI, documentation)
- 4
Assess fluid status for hypovolemia (prerenal AKI, clinical evaluation)
Ready-to-paste narrative
Patient presents with acute kidney injury (AKI), also known as acute renal failure, evidenced by a rapid decline in glomerular filtration rate (GFR) over [number] hoursdaysweeks. Presenting symptoms include [list symptoms e.g., oliguria, anuria, edema, fatigue, dyspnea, nausea, vomiting]. Serum creatinine is elevated at [value] mgdL, a significant increase from baseline [value] mgdL. Blood urea nitrogen (BUN) is also elevated at [value] mgdL. Urinalysis reveals [findings e.g., proteinuria, hematuria, casts]. The patient's medical history includes [list relevant medical history e.g., hypertension, diabetes, heart failure, nephrotoxic drug use]. Differential diagnosis includes prerenal azotemia, intrinsic renal failure, and postrenal obstruction. Initial treatment plan includes [list treatments e.g., intravenous fluids, monitoring of electrolytes and fluid balance, discontinuation of nephrotoxic medications]. Renal ultrasound ordered to evaluate for structural abnormalities and assess kidney size. The etiology of AKI is suspected to be [state suspected cause e.g., prerenal due to dehydration, intrinsic due to acute tubular necrosis, postrenal due to obstruction]. Prognosis and further management will depend on the underlying cause and the patient's response to initial therapy. ICD-10 code N17.9, Acute kidney failure, unspecified, is documented. This diagnosis will be continually reassessed and updated as the patient's condition evolves.
Common questions and answers
How can I differentiate prerenal acute kidney injury from intrinsic acute kidney injury in a clinically challenging patient?+
Differentiating prerenal AKI from intrinsic AKI requires a multifaceted approach considering clinical history, physical exam, and laboratory data. Prerenal AKI often stems from decreased renal perfusion, as seen in hypovolemia or heart failure, and typically responds to fluid resuscitation. Examine for signs of dehydration, hypotension, and assess cardiac function. Intrinsic AKI involves structural damage within the kidney, such as acute tubular necrosis (ATN) or glomerulonephritis. Look for a history of nephrotoxic drug exposure, autoimmune diseases, or recent infections. Laboratory markers can provide further clues. A fractional excretion of sodium (FENa) less than 1% often suggests prerenal AKI, while a FENa greater than 2% is more indicative of intrinsic AKI. However, FENa interpretation can be confounded by diuretic use. Urine microscopy can identify casts suggestive of ATN or glomerulonephritis. Explore how integrating these factors can improve diagnostic accuracy in complex cases of AKI. Consider implementing standardized protocols for AKI evaluation to ensure timely and appropriate management.
What are the latest evidence-based guidelines for managing acute kidney injury in patients with sepsis?+
Managing AKI in patients with sepsis necessitates a multidisciplinary approach focusing on prompt identification and treatment of the underlying infection while optimizing renal perfusion and function. The Surviving Sepsis Campaign guidelines emphasize early fluid resuscitation, vasopressor support if needed to maintain adequate mean arterial pressure, and appropriate antibiotic therapy. Renal replacement therapy (RRT) is indicated for life-threatening complications of AKI, such as severe fluid overload, refractory hyperkalemia, or metabolic acidosis. The choice of RRT modality, whether continuous venovenous hemofiltration (CVVH) or intermittent hemodialysis (IHD), should be individualized based on patient hemodynamic stability and resource availability. Close monitoring of fluid balance, electrolyte levels, and acid-base status is crucial. Learn more about the latest evidence-based strategies for preventing and managing AKI in critically ill septic patients to improve outcomes.
What are the key considerations when prescribing nephrotoxic medications to a patient with pre-existing chronic kidney disease (CKD) who develops acute kidney injury?+
Prescribing nephrotoxic medications to patients with pre-existing CKD and AKI requires careful consideration of the risks and benefits. A thorough medication review is essential to identify potentially nephrotoxic agents and consider alternative therapies if possible. If a nephrotoxic medication is unavoidable, dose adjustment based on estimated glomerular filtration rate (eGFR) and close monitoring of renal function are paramount. Serum creatinine and urine output should be monitored frequently, especially during the initial period of drug administration. Drug interactions should also be considered, as some medications can potentiate nephrotoxicity. For example, combining nonsteroidal anti-inflammatory drugs (NSAIDs) with aminoglycoside antibiotics can increase the risk of AKI. Consider implementing a pharmacy-driven renal dosing program to minimize the risk of medication-induced nephrotoxicity in vulnerable patients with CKD and AKI. Explore how collaborative medication management strategies can improve patient safety and outcomes.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.